Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Thai Health Minister Balks At Potential Sanctions Over Compulsory Licenses

This article was originally published in PharmAsia News

Executive Summary

Fearing possible U.S. sanctions, Thailand's new Health Minister Chaiya Sasomsab is reconsidering his predecessor's plan to seek compulsory licenses for at least three cancer treatments if the manufacturers declined to lower prices for the drugs

You may also be interested in...



Thailand’s Public Health Minister Asked To Step Down For Failing To Report Shareholdings

PERTH, Australia - Thailand's Public Health Minister Chaiya Sasomsab may have to step down from his post after failing to report his wife's shareholdings in a company, according to the Bangkok Post

Thailand’s Public Health Minister Asked To Step Down For Failing To Report Shareholdings

PERTH, Australia - Thailand's Public Health Minister Chaiya Sasomsab may have to step down from his post after failing to report his wife's shareholdings in a company, according to the Bangkok Post

Thai FDA Head “Surprised” By Health Minister’s Decision To Remove Him From Post – PharmAsia News Interview

PERTH, Australia - One of the main architects of the previous Thai government's compulsory license policy, FDA head Siriwat Tiptaradol told PharmAsia News that he does not know why the country's Public Health Minister Chaiya Sasomsab removed him from his post

Related Content

UsernamePublicRestriction

Register

OM006665

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel